About This Fund
The Invivo Ventures III Fund is focused on investing in the life sciences sector, particularly at the intersection of advanced therapies, synthetic biology, and artificial intelligence. The fund is managed by Invivo Partners, based in Barcelona, Spain. The fund is strategically designed to propel the emergent field of synthetic biology and invest in pioneering companies that reflect Invivo’s expertise and belief in the transformative potential of deep tech to address critical healthcare challenges. The fund's target investments include early-stage life science companies that are at the forefront of innovation. With a majority of private investors and the backing of significant institutional investors, Invivo Ventures III is poised to make a substantial impact in the life sciences ecosystem. Initial investments range from 2-4M€, with follow-ons in portfolio companies up to 10M€ per company after meeting set milestones. Europe is the geographical focus, being Spain the main target.